r3r01
Small moleculeexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jun 15, 2022 (NCT05267262)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- ATP-binding cassette sub-family A member 1Supplementation
ABCA1 supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06600412 | Phase 2 | Sep 18, 2024 | Region Hovedstadens Apotek, River 3 Renal Corp., Steno Diabetes Center Copenhagen, University of Copenhagen |
| NCT05267262 | Phase 2 | Jun 15, 2022 | River 3 Renal Corp. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| River 3 Renal Corp. | For profit | 2 | 2 | 1 | 2022 |
| Region Hovedstadens Apotek | Academic/Hospital | 1 | 0 | 1 | 2024 |
| Steno Diabetes Center Copenhagen | Academic/Hospital | 1 | 0 | 1 | 2024 |
| University of Copenhagen | Academic/Hospital | 1 | 0 | 1 | 2024 |
4 organizations
Page 1 / 1